Dendritic cell vaccines to combat glioblastoma.
Apr 2010 - Expert Rev Neurother; 10(4):1744-8360 [PMID:20367199]
[Wheeler CJ]

Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination.
Jan 2010 - J. Immunol. Methods; 352(1-2):1872-7905 [PMID:19874827]
[Ardon H] [Verbinnen B] [Maes W] [Beez T] [Van Gool S] [De Vleeschouwer S]

Dendritic cell vaccines for brain tumors.
Nov 2009 - Neurosurg. Clin. N. Am.; 21(1):1558-1349 [PMID:19944973]
[Kim W] [Liau LM]

Monitoring immune responses after glioma vaccine immunotherapy.
Nov 2009 - Neurosurg. Clin. N. Am.; 21(1):1558-1349 [PMID:19944978]
[Jian B] [Yang I] [Parsa AT]

Heat-shock protein vaccines as active immunotherapy against human gliomas.
Nov 2009 - Expert Rev Anticancer Ther; 9(11):1744-8328 [PMID:19895242]
[Yang I] [Han S] [Parsa AT]

Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours.
Oct 2009 - Pediatr Blood Cancer:1545-5017 [PMID:19852061]
[Ardon H] [De Vleeschouwer S] [Van Calenbergh F] [Claes L] [Kramm CM] [Rutkowski S] [Wolff JE] [Van Gool SW]

An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.
Oct 2009 - Mol. Cancer Ther.; 8(10):1538-8514 [PMID:19825799]
[Sampson JH] [Archer GE] [Mitchell DA] [Heimberger AB] [Herndon JE] [Lally-Goss D] [McGehee-Norman S] [Paolino A] [Reardon DA] [Friedman AH] [Friedman HS] [Bigner DD]

Brain tumor immunotherapy with type-1 polarizing strategies.
Sep 2009 - Ann. N. Y. Acad. Sci.; 1174:1749-6632 [PMID:19769732]
[Okada H]

Immunotherapy of diffuse gliomas: biological background, current status and future developments.
Sep 2009 - Brain Pathol.; 19(4):1750-3639 [PMID:19744040]
[Grauer OM] [Wesseling P] [Adema GJ]

Dendritic cell therapy of high-grade gliomas.
Sep 2009 - Brain Pathol.; 19(4):1750-3639 [PMID:19744041]
[Van Gool S] [Maes W] [Ardon H] [Verschuere T] [Van Cauter S] [De Vleeschouwer S]

Dendritic-cell- and peptide-based vaccination strategies for glioma.
Jun 2009 - Neurosurg Rev; 32(3):1437-2320 [PMID:19214609]
[Yamanaka R]

DCVax-Brain and DC vaccines in the treatment of GBM.
Apr 2009 - Expert Opin Investig Drugs; 18(4):1744-7658 [PMID:19335279]
[Wheeler CJ] [Black KL]

Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma.
Feb 2009 - Neurol. Res.; 31(1):0161-6412 [PMID:18937888]
[Zulkifli MM] [Ibrahim R] [Ali AM] [Aini I] [Jaafar H] [Hilda SS] [Alitheen NB] [Abdullah JM]

Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration.
Sep 2008 - Cancer Immunol. Immunother.; 57(12):0340-7004 [PMID:18369621]
[Driessens G] [Gordower L] [Nuttin L] [Stordeur P] [Blocklet D] [Egrise D] [Velu T] [Bruyns C]

[Immunotherapy for glioma]
Jul 2008 - Gan To Kagaku Ryoho; 35(6):0385-0684 [PMID:18652053]
[Izumoto S] [Yoshimine T]